AXA's updated fair value has moved from €48.51 to €51.99, with bullish analysts also lifting price targets into the low €50s. Some see the higher targets as a response to recent management actions and the reset in expectations, while more cautious voices point to slower profit growth and execution risk during the business reshaping. Read on to see how this split view is shaping the evolving AXA story and what it could mean for your watchlist.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
JPMorgan has raised its AXA price target multiple times in recent months, from €48 to €50 and then to €52, and maintains an Overweight stance. This signals confidence in the stock at current levels.
-
Morgan Stanley also increased its AXA price target from €46 to €48 while keeping an Overweight rating. This suggests the firm still sees support for the current valuation despite the business reshaping.
-
The clustering of targets from JPMorgan and Morgan Stanley around the high €40s to low €50s gives you a reference range that some analysts view as reasonable for AXA while the transformation plays out.
🐻 Bearish Takeaways
-
Erste Group downgraded AXA from Buy to Hold after the sale of its asset management division to BNP Paribas, highlighting that profit growth currently trails the sector average.
-
This more cautious stance points to execution risk around AXA's transformation and suggests that some analysts want clearer evidence on growth before turning more positive on the stock.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 1 risk for AXA. See which could impact your investment.
How This Changes the Fair Value For AXA
-
Fair Value has moved from €48.51 to €51.99, an increase of about 7% in the updated assessment for AXA.
-
Euro-denominated Revenue Growth has shifted from about 8.78% to about 10.86% in the new assumptions.
-
Euro-denominated Profit Margin has moved from about 7.77% to about 7.33% in the updated model.
-
The Future P/E has changed from about 11.4x to about 12.6x in the revised earnings multiple.
-
The Discount Rate has adjusted from 6.60% to about 6.63% in the latest model.
Never Miss an Update: Follow The Narrative
Narratives link AXA's business story to the analyst forecasts and fair value assumptions behind the price targets. They update as new information, risks, and catalysts are added to the picture.
Head over to the Simply Wall St Community and follow the Narrative on AXA to stay up to date on:
-
How AXA is using digitalization, AI, and direct distribution to improve efficiency and reach more price-sensitive and underserved customers.
-
The role of Health, Life & Savings, and emerging market expansion in supporting growth and broadening AXA's geographic footprint.
-
Key risks such as foreign exchange headwinds, softer insurance pricing, execution risk in the tech transformation, and higher climate related claims.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CS.PA .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
